PT
Primmune Therapeutics is a biotechnology company focused on developing immune-modulating therapies to enhance the body's response to viral infections. Their approach targets specific pathways in the immune system to improve patient outcomes in infectious diseases.
Updated 4 months ago
Funding
$8.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Primmune Therapeutics is a biotechnology company focused on developing immune-modulating therapies to enhance the body's response to viral infections. Their approach targets specific pathways in the immune system to improve patient outcomes in infectious diseases.